US NAT yield: where are we after 2 years?

Discussion of very recent literature, calculation of current risk of transfusion transmitted viral infections after introduction of NAT-HCV and NAT-HIV. Determination of cost/benefit of introduction of NAT. Conclusive statement that p24 antigen testing should be omitted after introducztion of NAT. – Volker Kretschmer

Transfusion practices for elective orthopedic surgery.

The article demonstrates that the decision towards autologous blood donation (ABD) does not, in the majority of cases, depend on the hemoglobin values but on additional health risk factors. There was even an increase of ABD from 1995/96 to 1998/99, which was not the case, for example, in Europe. Otherwise, the data confirm the generally […]

Fetal parvovirus B19 infection.

The article gives a good overview about incidence, pathogenesis, clinical symptoms, clinical course, diagnostics, therapy and prognosis of fetal parvovirus B19 infection by analysis of literature. The prognosis is mainly determined by the anemia. Data suggest a benefit of transfusion therapy. – V. Kretschmer.